https://www.qk.sjtu.edu.cn/jimcp/EN/abstract/article/1673-6087/51232
Olverembatinib combined with inotuzumab ozogamicin in Philadelphia chromosome-positive acute...
Relapsed/refractory (R/R) Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) is difficult to treat, facing a poor prognosis and short...
inotuzumab ozogamicinphiladelphia chromosomecombinedpositiveacute